Examining the Degree of Pain Reduction Using a Multielement Exercise Model with a Conventional Training Shoe Versus an Ultraflexible Training Shoe for Treating Plantar Fasciitis

Abstract

Plantar fasciitis is a common injury to the plantar aponeurosis, manifesting as pain surrounding its proximal insertion at the medial calcaneal tubercle. Pain is typically worse in the morning when getting out of bed, and may subside after the tissue is sufficiently warmed up. For running-based athletes and individuals who spend prolonged periods of time on their feet at work, plantar fasciitis may become recalcitrant to conservative treatments such as ice, rest, and anti-inflammatory medication. Exercise-based therapies have received only limited attention in the literature for this common problem, yet they are becoming increasingly validated for pain relief and positive tissue remodeling at other sites of similar soft-tissue overuse injury. This study reports on pain outcomes in individuals experiencing chronic plantar fasciitis whiles wearing a shoe with an ultraflexible midsole (Nike Free 5.0) (FREE) versus a conventional training (CON) shoe in a 12-week multielement exercise regimen, and after a 6-month follow-up. Adults with ≥ 6-month history of painful heel pain were recruited and randomly assigned to wear 1 of the 2 shoes. All subjects completed the same exercise protocol. A visual analogue scale item tracked peak pain in the preceding 24 hours taken at baseline, 6- and 12-week points, and at the 6-month follow-up. Twenty-one subjects completed the program (9 FREE; 12 CON). Both groups reported significant improvements in pain by the 6-month follow-up, and the FREE group reported an overall reduced level of pain throughout the study as a result of lower mean pain scores at the midpoint and post-test compared with the CON group. The exercise regimen employed in this study appears to reduce pain associated with chronic plantar fasciitis, and in doing so, the Nike 5.0 shoe may result in reductions in pain earlier than conventional running shoes.     

决策树C5.0与Logistic回归对产后压力性尿失禁预测性能的比较

目的 应用决策树C5.0和Logistic回归分别建立产后压力性尿失禁的风险预测模型,比较2种模型的预测效果.方法 选取2020年7月—2021年1月于山东省某三级甲等医院产后康复门诊就诊的女性505例,采用问卷调查法筛查产后压力性尿失禁并获取产妇的一般资料,采用生物反馈治疗仪评估产妇的盆底肌电值.将所有数据按照7:3...     

Libsys 5.0典藏模块在解放军医学图书馆新书典藏中的应用

介绍了Libsys 5.0典藏模块的各项功能,分析了Libsys 5.0典藏模块在我馆新书典藏中的应用。     

滞流区摩擦系数试验装置的改进

改进了滞流区摩擦系数的试验装置，试验数据用中文版Ｅｘｃｅｌ５．０处理，表图俱全，速度快。经验关联式与理论公式相当吻合。     

The BRCAPRO 5.0 model is a useful tool in genetic counseling and clinical management of male breast cancer cases

No study has evaluated the performance of BRCA1/2 mutations prediction models in male breast cancer (MBC) series. Although rare, MBC deserves attention because male and female breast cancers share many characteristics, including the involvement of genetic predisposition factors such as BRCA1/BRCA2 mutations. Indeed, the occurrence of MBC is a commonly used criterion to select families for BRCA mutation testing. We evaluated the performance and clinical effectiveness of four different predictive models in a population-based series of 102 Italian MBC patients characterized for BRCA1/2 mutations. Sensitivity, specificity, and positive and negative predictive values (PPV, NPV) were calculated for each risk model at the 10% threshold. The area under the ROC (AUC) curves and its corresponding asymptotic 95% CIs were calculated as a measure of the accuracy. In our study, the BRCAPRO version 5.0 had the highest combination of sensitivity, specificity, NPV and PPV for the combined probability and for the discrimination of BRCA2 mutations. In individuals with negative breast–ovarian cancer family history, BRCAPRO 5.0 reached a high discriminatory capacity (AUC=0.92) in predicting BRCA2 mutations and showed values of sensitivity, specificity, NPV and PPV of 0.5, 0.98, 0.97 and 0.67, respectively, for the combined probability. BRCAPRO version 5.0 can be particularly useful in dealing with non-familial MBC, a circumstance that often represents a challenging situation in genetic counseling.     

应用临床药物咨询系统V5.0分析我院11118张门诊处方

目的：利用大通医药咨询软件V5.0分析我院11118例门诊处方,为合理用药提供依据。方法：随机抽取2006年3、6和11月的处方应用临床药物咨询系统V5.0进行分析。结果：437张处方用药不合理,发生率为3.93%。结论：我院处方合理用药基本正常,应发挥临床药物咨询系统V5.0的更大作用,更应注意提高临床医务人员和药剂人员合理用药的意识、药理学的基础知识和药剂人员的调配技巧。     

Poser5.0在医学影像技术学中的应用

目的:制作多体位多视角的人体模型,获得多姿多彩、高清晰的人体模型图,以适应现代影像检查技术的教学需要,避免不必要的真人模特版权纠纷.方法:使用3D软件Poser 5.0,结合Macromedia Flash MX 2004制作出各种检查图及检查原理的视频动画等.结果:多媒体教学内容更加鲜明、生动、活泼,教与学都轻松,且易于理解和掌握.结论:使用Poser软件制作人体模型,适合影像检查技术的多媒体教学要求.     

活血化瘀法治疗冠心病心绞痛临床研究系统综述和Meta分析

[背景]活血化瘀法是治疗冠状动脉粥样硬化性心脏病的主要方法,疗效评价指标不一,临床研究多为小样本,影响结果可信度,疗效系统综述较少。[目的]评价活血化瘀法治疗冠心病心绞痛有效性和安全性。[检索策略]以主题词"活血化瘀"、"逐瘀"、"通瘀"、"通脉"、"通络"、"冠心病"、"心绞痛"、"胸痹"和"真心痛",检索中国生物医学文献数据库(CBM)、中国医院数字图书馆(CNKI)的期刊全文数据库、万方数据知识服务平台、维普中文期刊数据库(VIP)、Pubmed数据库、Embase数据库1998年1月至2012年12月文献。[纳入标准]随机对照试验(RCT)或半随机对照试验(CCT),病例资料完整;各文献研究假设及研究方法相似,组间均衡性较好。[资料提取与分析]采用RevMan5.0软件随机效应模型Meta分析。计数资料用比值比(OR),计量资料用加权均数差(WMD),计算95%可信区间(CI)。纳入文献异质性检验结果P0.05,采用固定效应模型作Meta分析;反之采用随机效应模型;然后采用敏感性分析检测Meta分析结果稳定性,对≥5篇分析结果,采用漏斗图分析发表性偏倚。[结果]纳入11篇文献,Meta分析结果:活血化瘀法可以明显改善冠心病心绞痛临床症状[OR=3.96,95%CI(2.62,5.98),(P0.001)];心电图改善率[OR=2.20,95%CI(1.64,2.95),(P0.001)];硝酸甘油停减率[OR=6.11,95%CI(3.68,10.13),(P0.001)];红细胞压积[WMD=-5.14,95%CI(-10.35,-0.07),(P0.001)];血液流变学中全血高切黏度[WMD=-0.42,95%CI(-0.72,-0.12),(P0.001)];全血低切黏度[WMD=-0.13,95%CI(-0.47,-0.22),(P0.001)];血浆黏度[WMD=-0.13,95%CI(-0.20,-0.06),(P0.001)];血脂中的甘油三酯[WMD=-0.26,95%CI(-0.48,-0.04),(P0.001)];总胆固醇[WMD=-0.62,95%CI(-1.58,-0.35),(P0.001)];高密度脂蛋白[WMD=0.12,95%CI(0.03,0.22),(P0.001)]。不良反应的发生率较低,症状较轻。[结论]活血化瘀法治疗冠心病心绞痛安全,有效。[问题与展望]前期研究质量不高,实验结果存在发表偏倚;目前对疗效尚不能得出最终结沦,有待于高质量临床研究,开展更多设计合理、执行严格、随访时间充足的具有中医特色的随机双盲对照试验。